Trademark: 88979456
Word
RXE2
Status
Registered
Status Code
700
Status Date
Tuesday, December 29, 2020
Serial Number
88979456
Registration Number
6235550
Registration Date
Tuesday, December 29, 2020
Mark Type
4000
Filing Date
Tuesday, January 7, 2020
Published for Opposition
Tuesday, June 2, 2020

Trademark Owner History
RXE2 LLC - Original Registrant

Classifications
39 Pharmacy packaging services, namely, packaging, labeling, aligning and sorting medication by date and time into individual packages and containers for patients and healthcare professionals; delivery of goods for others, namely, delivery of medication, device and clinical supply packages and containers by date and time and category for patients and healthcare providers
35 Pharmaceutical and pharmacy services, namely, processing and dispensing online and telephone prescription orders for online clinical and retail pharmacies; maintaining a registry of national and international databases in the field of pharmaceuticals, medical devices, clinical trials, and healthcare; maintaining databases of pharmacies, pharmacists, and other healthcare professionals who can assist with the delivery of pharmaceutical services; promoting the exchange of information and resources within the pharmaceutical, medical device, clinical trial, and medical communities to achieve advances in the fields of clinical research and healthcare; providing a website featuring statistical data and feedback on healthcare provider's performance for the purpose of assisting prospective patients in making physician, pharmacist, and other healthcare professional selection decisions; recruitment advertisement services, namely, posting of clinical trial notices for the purposes of providing clinical trial status, and recruiting and informing patients for participation in clinical trials for the testing of drugs and medical devices
44 Dispensing of medications by date and time and category for patients and healthcare providers; population health services, namely, gathering of global patient healthcare and behavioral data for the benefit of improving healthcare for individual patients, groups of patients, and populations; preparation of prescriptions in pharmacies; dispensing of pharmaceuticals; providing healthcare information; medical and pharmaceutical consultation; medical and pharmaceutical counseling via online or remote communication means; medical drug monitoring and alert service for healthcare providers and patients, namely, providing medication therapy management, medicinal dosage, allergic sensitivity, and prescription safety information for medical treatment purposes; telepharmacy services, namely, providing medical and pharmaceutical consultation and advice via online or remote communication means; providing information to patients in the field of administering, use and storage of medications; and providing medical information to patients in the form of reports in the field administering, use and storage of medications; and providing medical information to patients in the form of reports in the field of pharmaceuticals and medical devices
42 Pharmaceutical and medical device services, namely, providing pharmacist medical and scientific research counseling services to patients and healthcare providers as well as patients and healthcare providers participating in clinical trials for pharmaceutical, biotechnology, and medical device development and testing
RXE TWO

Trademark Events
Dec 29, 2020
Registered-Principal Register
Nov 26, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Nov 25, 2020
Allowed Principal Register - Sou Accepted
Nov 3, 2020
Statement Of Use Processing Complete
Oct 6, 2020
Use Amendment Filed
Nov 3, 2020
Divisional Processing Complete
Oct 6, 2020
Divisional Request Received
Oct 26, 2020
Case Assigned To Intent To Use Paralegal
Oct 6, 2020
Teas Statement Of Use Received
Oct 6, 2020
Teas Request To Divide Received
Jul 28, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 2, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 2, 2020
Published For Opposition
May 13, 2020
Notification Of Notice Of Publication E-Mailed
Apr 28, 2020
Assigned To Lie
Apr 22, 2020
Approved For Pub - Principal Register
Apr 1, 2020
Teas/Email Correspondence Entered
Mar 31, 2020
Correspondence Received In Law Office
Mar 31, 2020
Teas Response To Office Action Received
Mar 31, 2020
Notification Of Priority Action E-Mailed
Mar 31, 2020
Priority Action E-Mailed
Mar 31, 2020
Priority Action Written
Mar 26, 2020
Assigned To Examiner
Jan 10, 2020
New Application Office Supplied Data Entered
Jan 10, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24